Journal of Medicinal Chemistry

The Journal of Medicinal Chemistry (usually abbreviated as J. Med. Chem.), is a peer-reviewed scientific journal, published since 1959 by the American Chemical Society. It was originally published as the Journal of Medicinal and Pharmaceutical Chemistry, but changed its name in 1963 to the current title. Profs. Gunda I. Georg of the University of Minnesota and Shaomeng Wang of the University of Michigan are the Editors of the journal. They took over leadership from Prof. Philip S. Portoghese of the University of Minnesota in 2012. Prof. Portoghese had served as Editor in Chief from 1972 - 2011. The Journal of Medicinal Chemistry publishes original research on the correlation of molecular structure to biological activity with a focus on the relationships of chemistry to biological activity.

Impact factor
5.207 (2010)

Some content from Wikipedia, licensed under CC BY-SA

Cardiology

Artificial blood vessels become resistant to thrombosis

Scientists from ITMO University have developed artificial blood vessels that are not susceptible to blood clot formation. The achievement was enabled by a next-generation, drug-containing coating applied to the inner surface ...

Medical research

Study examines HIV drug's potential to treat Alzheimer's

A drug used to treat and prevent HIV/AIDS is showing promise as a potential therapy for Alzheimer's disease, and Vanderbilt University biochemist F. Peter Guengerich, Ph.D., is aiding efforts to make this approach to improving ...

Medical research

Saccharin derivatives give cancer cells a not-so-sweet surprise

Saccharin received a bad rap after studies in the 1970s linked consumption of large amounts of the artificial sweetener to bladder cancer in laboratory rats. Later, research revealed that these findings were not relevant ...

Diseases, Conditions, Syndromes

First proof a synthesized antibiotic is capable of treating superbugs

A "game changing" new antibiotic which is capable of killing superbugs has been successfully synthesised and used to treat an infection for the first time—and could lead to the first new class of antibiotic drug in 30 years.

Oncology & Cancer

A new approach to targeting cancer cells

A University of California, Riverside, research team has come up with a new approach to targeting cancer cells that circumvents a challenge faced by currently available cancer drugs.

page 1 from 6